NEW YORK (Reuters Health) – In patients with inflammatory bowel disease (IBD), a fecal wash sample yields more information about…
Browsing: Curated GI articles
Pre-existing fecal microbiome diversity was unaffected by gluten challenge in patients with celiac disease and nonceliac gluten sensitivity, according to data published…
An investigational oral microbiome treatment was 70% more effective than placebo in preventing Clostridioides difficile infection recurrence within eight weeks of treatment…
Over the years, Walmart has proven time and again its deep-rooted resilience, ability to adapt, and commitment to innovation. For…
NEW YORK (Reuters Health) – Colorectal cold-snare polypectomy is safe to perform if direct-acting oral anticoagulants (DOACs) are withheld on…
FORT LAUDERDALE, Fla., Feb. 14, 2022 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a…
At Janssen, we have made major strides in the treatment of inflammatory bowel disease (IBD) in recent years, but we…
Gastroparesis can be tricky to diagnose and treat, in part because its symptoms can be difficult to distinguish from functional…
Upper gastrointestinal (GI) bleeding is a severe acute disease associated with four main causes, namely, esophageal variceal bleeding, peptic ulcer…
The device, called the Endoculus, has been designed by a team at the Advanced Medical Technologies Laboratory (AMTL) at the…